STATEMENT FROM WICKLIFFE VETERINARY PHARMACY
LEXINGTON, Ky. (May 13, 2014) – Wickliffe Veterinary Pharmacy is a well-respected provider of customized medicinal solutions for veterinarians and the animals in its care. Wickliffe adheres to the highest safety, quality and validation standards of the compounding pharmacy profession and follows all applicable state and federal guidelines. Wickliffe was recently informed of adverse events involving horses that received a Toltrazuril/Pyrimethamine suspension compounded at its pharmacy. There is no known correlation between Wickliffe’s compound and the reported adverse events.
Wickliffe is working cooperatively with health authorities to determine the cause of the adverse events as quickly as possible. Wickliffe has no indication that the preparation compounded at its pharmacy was unsafe in any way, or prepared other than as prescribed.
Wickliffe is committed to the health and safety of its patients. Wickliffe has a strong reputation of providing excellent preparations to the equine industry, and continues to do so. Wickliffe pledges its expertise and full efforts to collaborate with equine professionals in determining the cause of these adverse events.
No comments:
Post a Comment